Dr. Michael Howard Kroll, MD

Dr. Kroll practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Kroll's NPI, 1710901863, was assigned on July 26, 2006. Dr. Kroll holds Texas license H7174.

Dr. Kroll's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Kroll's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kroll practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kroll's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kroll is licensed in Texas.

CMS data shows 282 Medicare services from Dr. Kroll across 8 procedure codes in 2024, for 282 Medicare patients. Medicare paid $21,386 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 282 Medicare patients who saw Dr. Kroll in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kroll's median patient age at 68, with 47% women.

In 2024, Dr. Kroll wrote 180 Medicare Part D claims for 70 patients. 27% of them were for generic drugs. CMS names the drug for 151 of them, across 3 drugs with 11 or more claims each, at $131,721 in total drug cost. In 2023, CMS named 105 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kroll for performance year 2024, reported as part of a group. Dr. Kroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Kroll, published from 2011 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Anticoagulants, Venous Thromboembolism and Platelet Count. Dr. Kroll has published most often in Eur Rev Aging Phys Act. Dr. Kroll's most frequent co-authors are Sanjay Gupta, MD, Trevor Wood, MD and Emilie V. Cheung, MD.

CMS Open Payments shows 7 general payments to Dr. Kroll from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Pfizer Inc. paid the most, $4,269.